Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells

Open Access
Publisher Website
Google Scholar
Abstract
Tay-Sachs disease is a severe neurodegenerative disorder due to mutations in the HEXA gene coding for the α-chain of the α-β heterodimeric lysosomal enzyme β-hexosaminidase A (HexA). Because no treatment is available for this disease, we have investigated the possibility of enzymatic correction of HexA-deficient cells by HEXA gene transfer. Human HEXA cDNA was subcloned into a retroviral plasmid generating to G.HEXA vector. The best Ψ-CRIP producer clone of G.HEXA retroviral particles was isolated, and murine HexA-deficient fibroblasts derived from hexa − mice were transduced with the G.HEXA vector. Transduced cells overexpressed the α-chain, resulting in the synthesis of interspecific HexA (human α-chain/murine β-chain) and in a total correction of HexA deficiency. The α-chain was secreted in the culture medium and taken up by HexA-deficient cells via mannose-6-phosphate receptor binding, allowing for the restoration of intracellular HexA activity in non-transduced cells.

This publication has 0 references indexed in Scilit: